WE HAVE PROPOSED that normal blood may interact with ischemically injured tissue and lead to progressive impairment of perfusion of that tissue despite anticoagulation.
1 ' 2 To test this hypothesis, we have developed a canine model of global ischemia of the central nervous system (CNS) by temporarily raising cerebrospinal fluid (CSF) pressure and then lowering it to normal to permit reentry of blood into ischemic vessels. 1 This sequence of "compression ischemia" followed by reperfusion regularly produces areas of diminished blood flow in the brain. These patches of underperfusion may represent the physiological equivalent of the neuropathologic "noreflow phenomenon". 3 ' 4 In an attempt to clarify the molecular pathogenesis of postischemic impairment of flow to the CNS, we undertook a study of what role prostaglandins (PG) might play in light of their known functions on hemostasis and the circulation. 5 - 6 We found that indomethacin, a potent inhibitor of PG synthetase, 7 eliminated the circulatory defects when the drug was infused prior to ischemia.
Methods
Fasting, male mongrel dogs weighing 8-14 kg were anesthetized with pentobarbital (25 mg/kg intravenously), intubated and ventilated mechanically on air with supplemental oxygen as necessary to maintain normal blood gases. After injection of heparin (300 units/kg intravenously), 6 dogs received a single dose of indomethacin intravenously over 5 minutes, 3 animals at 1.5 mg/kg and 3 at 4.0 mg/kg. Indomethacin (gift of Merck Sharp & Dohme, West Point, PA) was dissolved in an aqueous solution of sodium chloride (150 mM) and sodium carbonate (6.6 mM) to obtain a concentration of 2 mg/ml. The dosage of indomethacin was chosen to fall well within the usual therapeutic range in order to achieve en- zymatic inhibition rather than the nonspecific effects encountered at higher concentrations. 7 A control group of 6 dogs received no indomethacin. A spinal needle placed in the cisterna magna by suboccipital puncture was connected to a bottle of mock CSF. Ischemia of the CNS was induced 45 to 60 min after infusion of indomethacin by elevating the bottle of mock CSF above the animal until hydrostatic pressure in the line equalled mean arterial blood pressure (MABP). After 35 minutes of ischemia, the bottle was lowered to 10 torr (136 mm H 2 O) for 30 minutes of postischemic recirculation to the CNS. MABP was maintained between 70 and 90 torr during ischemia and systolic blood pressure between 110 and 120 torr during recirculation. Each experiment was concluded with a 1-minute autoradiographic blood flow study that used 14 C-antipyrine (100 ^Ci/kg). 8 The flow study was terminated by bolus injection into the right ventricle of saturated potassium chloride solution to stop the heart. (Further details of the animal model are available elsewhere. 1 ' 2 )
Results
Physiological data, including hemogram, arterial blood gases, heart rate and blood pressure, remained within normal ranges and did not differ substantively between control and experimental groups (table 1) . Cerebral autoradiograms from control animals exhibited multiple areas of low perfusion in the brain (Fig. 1A ) whereas no such areas were encountered in indomethacin-treated animals ( Fig. IB) . Local blood flow data derived from representative regions of the CNS are displayed in table 2. In the treated group, values for blood flow were greatly increased over those in control animals throughout the central neuraxis. In white-matter structures blood flows were comparable between animals receiving low-and high-dose indomethacin. In gray-matter structures blood flows tended to be greater in animals given the higher dosage, but statistical significance was not achieved between the small subgroups.
Discussion
This study demonstrates that prior treatment with indomethacin eliminates from within the CNS the poorly perfused areas that are regularly produced by our method of compression ischemia in the dog. 11500 ± 500*** 14400 ± 2300*** 10300 ± 1100*** 16300 ± 900*** Physiological variables monitored in control and indomethacin-treated animals. The values (mean ± SEM) were measured at four times during each experiment: a) during the control period, b) after one hour's observation in control animals or infusion of indomethacin in pretreated animals, c) at the end of compression ischemia and d) at the end of recirculation. No important differences between the two groups were apparent in regard to arterial blood gases, hemogram, or cardiovascular indices.
Instead, local blood flows were consistently the highest of any animals that we have subjected to compression ischemia and may have been higher were it not for limitations of the autoradiographic technique. 9 We attribute the enhanced flow to inhibition of PG synthesis by indomethacin but realize that this inhibi- tion may express itself through more than one mechanism involving blood vessels and blood itself.
Previous investigations have disclosed that indomethacin exerts disparate effects on the cerebral vasculature and circulation. When superfused directly on leptomeningeal arteries in the non-ischemic cat, the pharmacologic agent dilates the vessels and presumably increases local flow. 10 Similarly, indomethacin relaxes bovine cerebral vessels when superfused on them in vitro. 11 Infusion of very high doses of indomethacin (10-36 mg/kg) into the carotid artery of baboons is followed by a fall of some 30% in cerebral blood flow and by a corresponding rise in cerebrovascular resistance. Local blood flows in brain, spinal cord and heart when compression ischemia of the CNS follows various dosages of indomethacin. Values for cerebral blood flow (ml/100 g tissue/mjn) in the low-dose (1.5 mg/kg) and high-dose (4.0 mg/kg) groups are significantly different from those of the control group that received no drug (p values by Student (-test shown in parentheses). Blood flow in graymatter structures appears to be dose-dependent, but statistical significance was not reached between the small indomethacin-treated groups.
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produced in the cat by clamping both carotid arteries for 1 minute, indomethacin inhibits the expected reactive hyperemia. 13 (One explanation for the last-named action may be that the drug has abolished cerebrovascular dilatation in response to rising carbon-dioxide tension).
14 Despite apparent inconsistencies in the foregoing observations, it seems that parenteral indomethacin reduces cerebral blood flow under normal conditions and after reversible ischemia.
Protracted cerebral ischemia to the degree employed in the present model not only results in vasomotor paralysis to changes in CO 2 tension and perfusion pressure, 15 but, of course, causes some damage to the CNS. Damaged neural tissue can itself elaborate high levels of PG activity 16 that could further compromise already tenuous local flow of blood 17 unless PG synthesis is blocked beforehand as it is in this model.
In conjunction with its actions on cerebrovascular smooth muscle, indomethacin can alter plateletendothelial interactions which are mediated by labile compounds like thromboxane A 2 (TXA 2 ) 18 and prostacyclin (PGI 2 ). 19 Although occlusive platelet thrombi can be produced experimentally within the cerebral vasculature by infusion of the fatty acid precursor of TXA 2 , arachidonate, 20 ' 21 platelets per se have not been noted to figure prominently in the histopathology of the no-reflow phenomenon.
3 -" The possibility remains that prophylactic indomethacin may avert disturbance of the reciprocal relationship between the prohemostatic TXA 2 and the antihemostatic PGI 2 such that nutrient perfusion by the microcirculation is not disrupted following ischemia. Finally, one may speculate whether indomethacin also potentiates the "endogenous inhibitor of prostaglandin synthesis" (El PS), a plasmatic protein recently isolated in Cohn fraction IV-4.
22
In conclusion, the interactions between blood and ischemically injured neural tissue can be modified by administration of indomethacin before ischemia. Pretreatment with this drug presumably leads to blockade of PG synthetase and consequent suppression of hemostatic compounds generated during ischemia of the CNS. The relative absence of these compounds could explain the facilitation of postischemic perfusion of the CNS by the combined effects of a) interference with the constriction of resistance vessels in the cerebral vasculature and b) anti-hemostatic changes in blood. If maximal neurologic recovery from ischemia of the CNS depends upon the magnitude of blood flow in the immediate postischemic period, 23 ' 24 pharmacologic prophylaxis with a drug like indomethacin may prove salutary in patients predisposed to global ischemia of the CNS. However, preliminary observations in the dog indicate the drug is much less effective when given after cerebral ischemia. SUMMARY We measured the cerebral blood flow (CBF) of 16 patients by the xenon-133 intracarotid method before and after the intramuscular injection of ergotamine tartrate. The regional and hemispheric CBF was unaltered, even in 3 migraneurs in whom ergotamine relieved the headache. Ergotamine tartrate in therapeutic doses has no effect on the cerebral circulation.
Ergotamine and Cerebral
EVIDENCE for an ergotamine effect on the cerebral circulation is indirect and contradictory; therefore, we measured cerebral blood flow (CBF) directly, before and after the administration of therapeutic doses of ergotamine tartrate. 
Methods
Regional cerebral blood flow (rCBF) studies 1 were carried out prior to clinically indicated carotid arteriography in 16 patients. Their age, sex and diagnosis are listed in the table. Although cases 5, 6, 8, 10 and 11 were investigated because of suspected brain disease, no brain lesions were demonstrated; hence these patients were, in effect, non-migranous controls. Informed consent was obtained in all cases. Three millicuries of xenon-133 were injected through an indwelling catheter into the internal carotid artery. The intracarotid catheter was also used for mean arterial blood pressure (MABP) measurements and arterial blood gases analysis. The clearance rate of the isotope, and hence the rCBF, was measured by 16 extra-
